Atlas Trials

Suzhou Alphamab Co., Ltd.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Suzhou Alphamab Co., Ltd.

RecordFirmDate
Safety of KN057 Prophylaxis in Patients With Haemophilia A or B (NCT07545395)Suzhou Alphamab Co., Ltd.2026-03-13
KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors (NCT06747416)Suzhou Alphamab Co., Ltd.2025-09-02
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients (NCT07201467)Suzhou Alphamab Co., Ltd.2025-08-22
To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension (NCT07191899)Suzhou Alphamab Co., Ltd.2025-08-05
A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight (NCT06547775)Suzhou Alphamab Co., Ltd.2024-08-02
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors (NCT06569108)Suzhou Alphamab Co., Ltd.2024-04-01
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors (NCT06312475)Suzhou Alphamab Co., Ltd.2024-01-09
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (NCT06180889)Suzhou Alphamab Co., Ltd.2023-12-20
A Study to Evaluate Effects of KN056 in Healthy Participants (NCT05385575)Suzhou Alphamab Co., Ltd.2022-08-09
KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia (NCT05421429)Suzhou Alphamab Co., Ltd.2022-07-07

Track Suzhou Alphamab Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.